Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ANAVEX LIFE SCIENCES CORP. (AVXL)
|
Add to portfolio |
|
|
|
| Price: |
$13.43
| | Metrics |
| OS: |
82.0
|
M
| |
|
|
| Market cap: |
$1.1
|
B
| |
-10038
|
% ROIC
|
|
Net cash:
|
$155
|
M
| |
$1.89
|
per share
|
|
EV:
|
$946
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($59.9)
|
M
| |
|
|
|
EBIT
|
($59.9)
|
M
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | | | |
| Selling, general and administrative | | | | | | | | |
| Research and development | 37.9 | 33.0 | 25.2 | 22.3 | 13.3 | 10.7 | 7.3 | 2.3 |
| General and administrative | 13.1 | 9.0 | 5.9 | 6.8 | 6.0 | 5.0 | 8.3 | 4.8 |
| EBIT | -51.0 | -42.0 | -31.1 | -26.3 | -17.5 | -13.5 | -14.8 | -12.0 |
| EBIT margin | | | | | | | | |
| Pre-tax income | -47.6 | -37.6 | -26.3 | -26.2 | -17.2 | -13.4 | -14.7 | -12.1 |
| Income taxes | -0.4 | -0.3 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Tax rate | 0.8% | 0.7% | 0.1% | | | | | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | -26.3 | -17.3 | -13.5 | -14.7 | -12.1 |
| Net margin | | | | | | | | |
| |
| Diluted EPS | | $0.00 | $0.00 | ($0.54) | ($0.39) | ($0.33) | ($0.42) | ($0.65) |
| Shares outstanding (diluted) | | 69.8 | 58.2 | 48.9 | 44.7 | 40.8 | 35.2 | 18.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|